(30,31) The authors acknowledged several limitations, including the use of a national patient database, which restricted their ability to control for prior diabetes management and preoperative glycemic control
Unbound (bioavailable) IGF1 enhances somatic growth
Other documented side effects include injection site reactions, fatigue, hypoglycemia (particularly when used with insulin or sulfonylureas), and increased heart rate (average increase of 2-4 beats per minute)
Most medical guidelines recommend waiting until weaning due to incomplete evidence about transmission into breast milk and potential effects on infants
At this stage, theres no evidence to suggest people should avoid or stop treatment based on this concern alone
Yes, many patients begin GLP-1 programs entirely via telemedicine, provided their state and clinical history allow virtual prescribing